Oligometastatic Breast Cancer: A Debate on the Evidence
Date: Monday Nov 2, 2026 Format: Expert Debate and Interactive Discussion The program will feature a distinguished debate between internationally recognized leaders in oligometastatic disease management:
Dr. Jillian Tsai – Principal Investigator of the CURB trial
Dr. David Krug – Principal Investigator of the OLIGOMA trial
Through a dynamic debate-style format, attendees will gain insight into the latest evidence, ongoing controversies, and future directions in the management of oligometastatic breast cancer. The event is expected to attract radiation oncologists, medical physicists, radiation therapists, trainees, and other oncology professionals from across Canada and internationally.